NO924926L - TRANSDERMAL ADMINISTRATION OF BUPRENORPHINE - Google Patents
TRANSDERMAL ADMINISTRATION OF BUPRENORPHINEInfo
- Publication number
- NO924926L NO924926L NO92924926A NO924926A NO924926L NO 924926 L NO924926 L NO 924926L NO 92924926 A NO92924926 A NO 92924926A NO 924926 A NO924926 A NO 924926A NO 924926 L NO924926 L NO 924926L
- Authority
- NO
- Norway
- Prior art keywords
- buprenorphine
- transdermal administration
- administration
- enhancer
- cra2
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Fremgangsmåte og laminert kompositt for administrering av buprenorfin transdermalt for å behandle smerte. Komposltten omfatter et ugjennomtrengelig baklag og et reservoarlag som inneholder buprenorfin og eventuelt en gjennomtrengningsforøker kombinert med et trykk- sensitivt adhesiv og med mengder buprenorfin og eventuell forøker som er tilstrekkelig til å forårsake at buprenorfin passerer gjennom huden ved en hastighet som er over ca. 0,05 >jg/cra2/t.Method and laminated composite for the administration of buprenorphine transdermally to treat pain. The composite comprises an impermeable backing and a reservoir layer containing buprenorphine and optionally a permeation enhancer combined with a pressure sensitive adhesive and with amounts of buprenorphine and any enhancer sufficient to cause buprenorphine to pass through the skin at a rate greater than ca. 0.05> µg / cra2 / t.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/540,908 US5069909A (en) | 1990-06-20 | 1990-06-20 | Transdermal administration of buprenorphine |
PCT/US1991/004189 WO1991019474A1 (en) | 1990-06-20 | 1991-06-12 | Transdermal administration of buprenorphine |
Publications (2)
Publication Number | Publication Date |
---|---|
NO924926D0 NO924926D0 (en) | 1992-12-18 |
NO924926L true NO924926L (en) | 1993-02-04 |
Family
ID=26783205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO92924926A NO924926L (en) | 1990-06-20 | 1992-12-18 | TRANSDERMAL ADMINISTRATION OF BUPRENORPHINE |
Country Status (1)
Country | Link |
---|---|
NO (1) | NO924926L (en) |
-
1992
- 1992-12-18 NO NO92924926A patent/NO924926L/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO924926D0 (en) | 1992-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU533491B2 (en) | Bandage for administering drugs to the skin | |
MY103740A (en) | Transdermal therapeutic system | |
NO940590L (en) | Transdermal administration of benzodiazepines with short or medium half-lives | |
CA2064687A1 (en) | Method and device for administering dexmedetomidine transdermaly | |
DK0697860T3 (en) | Estradiol-containing transdermal therapeutic system | |
IL124279A (en) | Transdermal therapeutic systems containing hmg-coa reductase inhibitors | |
IE46069L (en) | Adhesive skin patch | |
ZA951427B (en) | Drug containing adhesive composite transdermal delivery device | |
PL335410A1 (en) | Medium for transcutaneous testosterone administration | |
DE69923348D1 (en) | TRANSDERMAL MEDICINE ADMINISTRATION SYSTEM | |
DE69916492D1 (en) | PLASTER FOR THE TRANSDERMAL APPLICATION OF VOLATILE, LIQUID ACTIVE SUBSTANCES | |
EP0138551A3 (en) | A system for the transdermal delivery of nitroglycerin | |
PL307786A1 (en) | Plaster for percutaneous administration of systemically acting steroid hormones | |
HRP930991A2 (en) | Transdermal therapeutic system containing the active tance 17-beta-oestradiol and the process for the production eof | |
CA2403949A1 (en) | Transdermal therapeutic system for the delivery of lerisetron | |
AU2001230193A1 (en) | Transdermal therapeutic system for the administration of zaleplon | |
NO924926L (en) | TRANSDERMAL ADMINISTRATION OF BUPRENORPHINE | |
MY113222A (en) | Medicinal patches for percutaneous administration | |
PL319013A1 (en) | Transdermal therapeutic system containing estradiol and water bonding additives | |
PL308531A1 (en) | Percutaneous therapeutic system for applying physostygmine onto skin and method of obtaining same | |
GR3002566T3 (en) | Dermal and transdermal therapeutic system having a discontinuous-pattern adhesive layer and method of manufacturing thereof | |
MX9704291A (en) | Transdermal delivery system with adhesive overlay and peel seal disc. |